CAPITAL STOCK AND ADDITIONAL PAID IN CAPITAL | 6. CAPITAL STOCK AND ADDITIONAL PAID IN CAPITAL The holders of common stock are entitled to one vote for each share held. There are no restrictions that limit the Company’s ability to pay dividends on its common stock. The Company has not declared any dividends since incorporation. The Company’s common stock has no par value per common share. During the year ended December 31, 2022, the Company issued 37,803,218 units as part of a private placement valued at CAD$0.09 per unit. Each units consists of one common share and one share purchase warrant. Each warrant will entitle the holder thereof to purchase one common share in the capital of the Company at an exercise price of CAD$0.1075 at any time up to 5 years following the date of issuance. The warrants attached to the private placement are classified as a derivative liability at an initial value of $1,781,779. During the year ended December 31, 2021, there were no share issuances pursuant to private placements. During the year ended December 31, 2022, the holders of 900,000 stock options exercised their options for 900,000 shares for $106,989 (CAD$135,000) at an exercise price of CAD$0.15 per share. During the year ended December 31, 2021, the holders of 3,125,000 stock options exercised their options for 3,125,000 shares for $297,815 (CAD$378,575) at an average exercised price of CAD$0.12. Warrants A summary of warrant activity for the year ended December 31, 2022, are as follows: Number of warrants Exercise price Expiry date Outstanding December 31, 2021, and 2020 - - - Granted 37,803,218 CAD$0.1075 May 20 - June 14, 2027 Outstanding December 31, 2022 37,803,218 CAD$0.1075 A fair value of the derivative liability of $1,781,779 was estimated on the date of the subscription using the Black-Scholes pricing model. For the year ended December 31, 2022, there was a non-cash gain on derivative liability – warrants of $525,259 and an unrealized foreign exchange gain of $61,635 resulting in a fair value as at December 31, 2022 of $1,194,885 with the following weighted average assumptions: December 31, 2022 Issuance date Exercise price CAD$0.1075 CAD$0.1075 Stock price CAD$0.07 CAD$0.09 Expected term 4.5 years 5 years Expected dividend yield - - Expected stock price volatility 91.71 % 85.69 % Risk-free interest rate 2.75 % 2.73 % Stock Options The Company established a stock option plan (the “Plan”) under which it is authorized to grant options to executive officers and directors, employees and consultants and the number of options granted under the Plan shall not exceed 10% of the shares outstanding. Under the Plan, the exercise period of the options may not exceed ten years from the date of grant and vesting is determined by the Board of Directors. The exercise price is determined by the Board of Directors. Stock option transactions are summarized as follows: Stock Options Number Weighted average exercise price in Canadian $ Outstanding, December 31, 2020 35,100,000 $ 0.17 Granted 6,175,000 0.18 Exercised (3,125,000 ) 0.12 Expired (3,535,000 ) 0.16 Outstanding, December 31, 2021 34,615,000 0.18 Granted 5,700,000 0.09 Exercised (900,000 ) 0.15 Expired (4,750,000 ) 0.37 Outstanding, December 31, 2022 34,665,000 $ 0.14 Number currently exercisable 31,815,000 $ 0.14 As at December 31, 2022, incentive stock options were outstanding as follows: Number of Options (outstanding) Number of Options (exercisable) Exercise Price in Canadian $ Expiry Date Options 5,700,000 5,700,000 0.225 January 19, 2023* 350,000 350,000 0.185 August 30, 2023 3,240,000 3,240,000 0.150 May 9, 2024 50,000 50,000 0.130 June 24, 2024 7,450,000 7,450,000 0.065 March 19, 2025 100,000 100,000 0.075 May 22, 2025 5,900,000 5,900,000 0.140 November 13, 2025 6,175,000 6,175,000 0.180 May 23, 2026 5,700,000 2,850,000 0.090 June 14, 2027 34,665,000 31,815,000 *Options expired subsequent to December 31, 2022, unexercised. As at December 31, 2022 the Company’s outstanding and exercisable stock options have an aggregate intrinsic value of $Nil (2021 - $445,466). Stock-based compensation During the year ended December 31, 2022, the Company recognized stock-based compensation of $198,280 (December 31, 2021 - $610,385) in the statement of profit or loss pursuant to stock options granted and vested. There were 5,700,000 stock options granted during the year ended December 31, 2022 (December 31, 2021 – 6,175,000). The weighted average fair value of the options granted in the year was CAD$0.06 (2021 - CAD$0.18). The fair value of all compensatory options granted is estimated on grant date using the Black-Scholes option pricing model. The weighted average assumptions used in calculating the fair values of stock options granted in the years ended December 31,2022 and December 31, 2021 are as follows: 2022 2021 Risk-free interest rate 2.79 % 0.32 % Expected life 5 years 5 years Volatility 85.52 % 87.19 % Forfeiture rate 0.00 % 0.00 % Dividend rate 0.00 % 0.00 % |